Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ED50 of propofol for laryngeal mask airway insertion in children
ChiCTR2100043532Phase 4Recruiting
- Sponsor
- Shanghai Children's Medical Center
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of propofol in None, sponsored by Shanghai Children's Medical Center. Primary endpoint: ED50 of propofol for laryngeal mask insertion response suppression. Started Mar 2021; status: recruiting.
02
Drugs
propofol
Beyond the preview
Go deeper on ChiCTR2100043532.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100043532.